Developing Novel Drugs for Treatment and Diagnosis of Cancer
find. treat. follow

Novelos News

NOVELOS THERAPEUTICS PROVIDES PRODUCT PIPELINE UPDATE

Download PDF Download release

NOVELOS THERAPEUTICS CLOSES $5.5 MILLION PUBLIC OFFERING

Download PDF Download release

NOVELOS THERAPEUTICS PRICES $5.5 MILLION PUBLIC OFFERING

Download PDF Download release

NOVELOS THERAPEUTICS TO PRESENT AT THE 15th ANNUAL BIO CEO & INVESTOR CONFERENCE ON FEBRUARY 11

Download PDF Download release

NOVELOS THERAPEUTICS PRESENTS DIAPEUTIC TECHNOLOGY PLATFORM AT EMIT: TARGETED RADIOTHERAPY INTERNATIONAL CONFERENCE

Download PDF Download release

NOVELOS THERAPEUTICS TO PRESENT AT THE BENCHMARK 2012 MICRO CAP DISCOVERY INVESTOR CONFERENCE ON NOVEMBER 29

Download PDF Download release

NOVELOS THERAPEUTICS CLOSES $2 MILLION PRIVATE PLACEMENT

Download PDF Download release

NOVELOS THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN SOLID TUMOR IMAGING TRIAL WITH I-124-CLR1404 (LIGHT) CANCER-TARGETED PET IMAGING AGENT AT UW CARBONE CANCER CENTER

Download PDF Download release

NOVELOS THERAPEUTICS AND ACADEMIC COLLABORATORS PRESENT DIAPEUTIC TECHNOLOGY PLATFORM AT IMAGING IN 2020 CONFERENCE

Download PDF Download release

NOVELOS THERAPEUTICS TO PRESENT AT 11th ANNUAL BIO INVESTOR FORUM ON OCTOBER 10

Download PDF Download release

NOVELOS THERAPEUTICS SUCCESSFULLY COMPLETES SECOND COHORT IN PHASE 1b SOLID TUMOR TRIAL WITH I-131-CLR1404 (HOT) CANCER-TARGETED MOLECULAR RADIOTHERAPEUTIC

Download PDF Download Release

NOVELOS THERAPEUTICS AND ACADEMIC COLLABORATORS PRESENT THREE POSTERS AT 2012 WORLD MOLECULAR IMAGING CONGRESS

Download PDF Download release

NOVELOS THERAPEUTICS TO PRESENT AT RODMAN & RENSHAW 14th ANNUAL HEALTHCARE CONFERENCE ON SEPTEMBER 11

Download PDF Download release

NOVELOS THERAPEUTICS DEVELOPING CLR1502 (GLOW2) CANCER-TARGETED OPTICAL IMAGING AGENT FOR INTRAOPERATIVE TUMOR MARGIN ILLUMINATION

Download PDF Download release

NOVELOS THERAPEUTICS TO PRESENT AT LHA LIFE SCIENCES & MEDICAL TECHNOLOGIES VIRTUAL CONFERENCE ON JUNE 28

Download PDF Download release

NOVELOS THERAPEUTICS ANNOUNCES POSITIVE INITIAL IMAGING RESULTS IN BRAIN CANCER TRIAL WITH I-124-CLR1404 (LIGHT) CANCER-TARGETED PET IMAGING AGENT AT UW CARBONE CANCER CENTER

Download PDF Download release

NOVELOS THERAPEUTICS CLOSES $5.4 MILLION PUBLIC OFFERING

Download PDF Download release

NOVELOS THERAPEUTICS PRICES $5.4 MILLION PUBLIC OFFERING

Download PDF Download release

NOVELOS THERAPEUTICS SUCCESSFULLY COMPLETES FIRST COHORT IN PHASE 1b SOLID TUMOR TRIAL WITH I-131-CLR1404 (HOT) CANCER-TARGETED MOLECULAR RADIOTHERAPEUTIC

Download PDF Download release

NOVELOS THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF FIRST COHORT IN LUNG CANCER TRIAL WITH I-124-CLR1404 (LIGHT) CANCER-TARGETED PET IMAGING AGENT AT UW CARBONE CANCER CENTER

Download PDF Download release